ClinicalTrials.Veeva

Menu

Effect of Higher Volume and Lower Dose on Analgesic Quality During Labor Analgesia With Dural Puncture Epidural

A

Ataturk University

Status

Enrolling

Conditions

Analgesia

Treatments

Procedure: Group I: Lower Volume with Higher Anaesthetic Concentration
Procedure: Group II: Higher Volume with LowerAnaesthetic Concentration

Study type

Interventional

Funder types

Other

Identifiers

NCT06156709
B.30.2.ATA.0.01.00/829

Details and patient eligibility

About

It is aimed in this study to compare the effect of using local anaesthetics in a higher volume and lower dose on the total anesthetic consumption and quality of labor analgesia with dural puncture epidural technique.

Full description

This study will be conducted as a prospective randomized, controlled, double-blind trial following the approval of the ethical committee at Atatürk University Medical Faculty Hospital and after obtaining written consent from the participating patients. The study will include pregnant women aged 20 to 45 with American Society of Anesthesiologists (ASA) II classification, full-term, nulliparous and singleton pregnancies. Using a randomisation procedure, the participants will be allocated into two equal groups: Group I and Group II.

Enrollment

54 estimated patients

Sex

Female

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy nulliparous women
  2. American Society of Anaesthesiology Score of II
  3. During active labor
  4. At weeks 37-42.
  5. Singlet vertex presentation
  6. Cervical dilation <5 cm at the request of labor analgesia
  7. VAS score >40

Exclusion criteria

  1. Age <20 or >45,
  2. Morbid obesity
  3. Presence of pregnancy-related comorbidities (e.g: gestational diebetes, gestational hypertension and preeclampsia)
  4. History of drug abuse
  5. Contrindication for neuraxial blocks
  6. Conditions that increase the risk of need for cesarean section (e.g. placenta previa, uterus abnormalities or surgeries)
  7. Diagnosed fetal abnormalities
  8. Cases where dura gets punctured unintendedly with the epiduralneedle
  9. Cases where flow of cerebrospinal fluid (CSF) is not observed after dural puncture
  10. Cases where a cesarean section is performed at any stage of labor
  11. Cases where labor is completed in 1 hour from the start of analgesia procedure.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

54 participants in 2 patient groups

Group I
Active Comparator group
Description:
The patients will be given 10 ml of a solution containing 0,1% of bupivacaine and 2 mcg/ml fentanyl through the epidural cathether. Level of sensory block will be tested by testing with ice from S2 dermatome cephally. Analgesia will be maintained by programmed intermittant epidural (PIE) boluses of 7,5 ml of the same solution once in every hour, starting 1 hour after the loading dose. In addition, patient controlled epidural analgesia (PCEA) will be programmed so that 8 ml of the same solution with a lock-time of 10 ml may be administered. "Breakthrough pain" that requires even further analgesia will be treated with an epidural bolus of 5 ml of 0,125% bupivacain solution.
Treatment:
Procedure: Group I: Lower Volume with Higher Anaesthetic Concentration
Group II
Active Comparator group
Description:
The patients will be given 20 ml of a solution containing 0,0625% of bupivacaine and 2 mcg/ml fentanyl through the epidural cathether. Analgesia will be maintained by programmed intermittant epidural boluses of 15 ml of the same solution once in every hour, starting 1 hour after the loading dose. In addition, patient controlled epidural analgesia (PCEA) will be programmed so that 8 ml of the same solution with a lock-time of 10 ml may be administered. "Breakthrough pain" that requires even further analgesia will be treated with an epidural bolus of 5 ml of 0,125% bupivacain solution.
Treatment:
Procedure: Group II: Higher Volume with LowerAnaesthetic Concentration

Trial contacts and locations

1

Loading...

Central trial contact

Ayşenur Dostbil; Ayşenur Dostbil

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems